Related Experiment Video
Updated: Mar 11, 2026
Implantation of an Isoproterenol Mini-Pump to Induce Heart Failure in Mice
Published on: October 3, 2019
CB-Receptor Agonist HU-210 Mimics the Postconditioning Phenomenon of Isolated Heart
A S Gorbunov1, L N Maslov2, S Yu Tsibulnikov1
1Research Institute for Cardiology, Tomsk, Russia.
Insights
The cannabinoid receptor agonist HU-210 limits heart damage after ischemia and reperfusion. It reduces cardiac workload and calcium overload in heart cells.
Area of Science:
- Cardiovascular Science
- Pharmacology
- Cell Biology
Background:
- Focal ischemia followed by reperfusion causes significant heart damage.
- Cannabinoid receptors play a role in cardiovascular function.
- Cardiomyocyte calcium overload is a key factor in reperfusion injury.
Purpose of the Study:
- To investigate the protective effects of the cannabinoid receptor agonist HU-210 on heart tissue during reperfusion after focal ischemia.
- To assess the impact of HU-210 on cardiac function and cellular calcium handling.
Main Methods:
- In vitro model of focal ischemia and reperfusion in heart tissue.
- Administration of the cannabinoid receptor agonist HU-210.
- Measurement of left-ventricular developed pressure and double product.
- Monitoring of end-diastolic pressure.
Main Results:
- HU-210 demonstrated an infarction-limiting effect during reperfusion.
- A decrease in left-ventricular developed pressure and double product was observed with HU-210 treatment.
- HU-210 reduced end-diastolic pressure, suggesting decreased calcium overload.
Conclusions:
- The cannabinoid receptor agonist HU-210 offers protective benefits against ischemia-reperfusion injury in the heart.
- HU-210 may mitigate cardiac dysfunction and cardiomyocyte calcium overload during reperfusion.
- Targeting cannabinoid receptors could be a therapeutic strategy for heart attack recovery.
Abstract:
CB receptor agonist HU-210 exhibits an infarction-limiting effect during in vitro reperfusion of the heart after focal ischemia. This effect is paralleled by a decrease in left-ventricular developed pressure and double product. In addition, HU-210 reduces end-diastolic pressure during the reperfusion period, which indirectly attests to reduced Ca2+ overload of cardiomyocytes.
